Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes - PubMed (original) (raw)

Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes

M K Slifka et al. J Virol. 1996 May.

Abstract

Listeria monocytogenes is a facultative intracellular bacterium that is able to escape phagocytic vesicles and replicate in the cytoplasm of infected cells. As with viral vectors, this intracytoplasmic life cycle provides a means for introducing foreign proteins into the major histocompatibility complex class I pathway of antigen presentation. Using recombinant L. monocytogenes (rLM) strains expressing the full-length nucleoprotein (NP) or a single cytotoxic T-lymphocyte (CTL) epitope from lymphocytic choriomeningitis virus (LCMV), we analyzed antiviral CTL responses induced by rLM vaccination. After vaccination, rLM was cleared from the host within 7 days while inducing an LCMV-specific ex vivo CD8+ effector CTL response. Virus-specific CTL memory was maintained for 6 months postvaccination, as demonstrated by vigorous secondary CTL responses after in vitro stimulation. A single immunization with rLM that expressed either the full-length NP gene or the CTL epitope alone resulted in LCMV NP-specific CTL precursor frequencies of approximately 1/10(4) CD8+ T cells. A second rLM vaccination resulted in enhanced virus-specific CTL activity and in vitro proliferation. rLM-vaccinated mice were protected against chronic viral infection by an accelerated virus-specific memory CTL response. These mice cleared infectious virus as well as viral antigen, suggesting that sterilizing immunity was achieved. In contrast to mice that received wild-type LM, rLM-vaccinated mice were protected from virally induced immunosuppression and splenic atrophy associated with chronic LCMV infection. The ability to elicit long-term cell-mediated immunity is fundamental in designing vaccines against intracellular pathogens, and these results demonstrate the efficacy of recombinant LM vaccination for inducing protective antiviral CTL memory.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Immunobiology. 1992 Feb;184(2-3):126-46 - PubMed
    1. J Immunol. 1981 Apr;126(4):1614-9 - PubMed
    1. J Immunol. 1992 Jul 1;149(1):53-9 - PubMed
    1. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11612-6 - PubMed
    1. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3725-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources